JULIA BOS: Open Payments
NPI 1144937822 · ADA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,291 in 136 payments from 16 companies in 2025. Trend: 2023 $1,051 · 2024 $2,055 · 2025 $2,291
Food & beverage: $2,291
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $883 |
| Amgen Inc. | 31 | $465 |
| Novartis Pharmaceuticals Corporation | 17 | $245 |
| AstraZeneca Pharmaceuticals LP | 7 | $205 |
| UCB, Inc. | 4 | $132 |
| E.R. Squibb & Sons, L.L.C. | 2 | $74 |
| Janssen Biotech, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $39 |
| Organon LLC | 4 | $37 |
| Fresenius Kabi USA, LLC | 1 | $29 |
Products named: RINVOQ, SKYRIZI, ENBREL, COSENTYX, SAPHNELO, OTEZLA, Bimzelx, ORENCIA.
Industry payments across MI — which companies pay providers there.
